Improving adherence to antiretroviral treatment in Uganda with a low-resource facility-based intervention

References

• Agnarson AM, Masanja H, Ekstrom AM, Eriksen J, Tomson G, Thorson A. Challenges to ART scale-up in a rural district in Tanzania: stigma and distrust among Tanzanian health care workers, people living with HIV and community members. Trop Med Int Health. 2010; 15: 1000–7. [PubMed Abstract].
   Google Scholar
• Cooke GS, Tanser FC, Barnighausen TW, Newell ML. Population uptake of antiretroviral treatment through primary care in rural South Africa. BMC Public Health. 2010; 10: 585. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Hanefeld J. The impact of Global Health Initiatives at national and sub-national level—a policy analysis of their role in implementation processes of antiretroviral treatment (ART) roll-out in Zambia and South Africa. AIDS Care. 2010; 22(Suppl 1): 93–102. [PubMed Abstract].
   Google Scholar
• Uebel KE, Timmerman V, Ingle SM, van Rensburg DH, Mollentze WF. Towards universal ARV access: achievements and challenges in Free State Province, South Africa. S Afr Med J. 2010; 100: 589–93. [PubMed Abstract].
   Google Scholar
• World Health Organization, UNAIDS. Progress on global access to HIV antiretroviral therapy. A report on “3 by 5” and beyond. 2006; Geneva: WHO. 2006. http://www.who.int/hiv/progreport2006_en.pdf [cited 2014 January]..
   Google Scholar
• García de Olalla P, Knobel H, Carmona A, Guelar A, López-Colomés JL, Caylà JA. Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. J Acquir Immune Defic Syndr. 2002; 30: 105–10.
   PubMed Web of Science ®Google Scholar
• Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, etal. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001; 15: 1181–3. [PubMed Abstract].
   Google Scholar
• Chalker JC, Andualem T, Gitau LN, Ntaganira J, Obua C, Tadeg H, etal. Measuring adherence to antiretroviral treatment in resource-poor settings: the feasibility of collecting routine data for key indicators. BMC Health Serv Res. 2010; 10: 43. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Gusdal AK, Obua C, Andualem T, Wahlstrom R, Tomson G, Peterson S, etal. Voices on adherence to ART in Ethiopia and Uganda: a matter of choice or simply not an option?. AIDS Care. 2009; 21: 1381–7. [PubMed Abstract].
   Google Scholar
• Miller C, Tsoka MG. ARVs and cash too: caring and supporting people living with HIV/AIDS with the Malawi Social Cash Transfer. Trop Med Int Health. 2012; 17: 204–10. [PubMed Abstract].
   Google Scholar
• Schouten EJ, Jahn A, Ben-Smith A, Makombe SD, Harries AD, Aboagye-Nyame F, etal. Antiretroviral drug supply challenges in the era of scaling up ART in Malawi. J Int AIDS Soc. 2011; 14(Suppl 1): S4. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Ross-Degnan D, Pierre-Jacques M, Zhang F, Tadeg H, Gitau L, Ntaganira J, etal. Measuring adherence to antiretroviral treatment in resource-poor settings: the clinical validity of key indicators. BMC Health Serv Res. 2010; 10: 42. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Sanjobo N, Frich JC, Fretheim A. Barriers and facilitators to patients’ adherence to antiretroviral treatment in Zambia: a qualitative study. SAHARA J. 2008; 5: 136–43. [PubMed Abstract].
   Google Scholar
• WHO and Management Sciences for Health. How to investigate adherence to antiretroviral treatment: an indicator-based approach. 2011. Geneva: WHO/EMP/MIE/2011.1.
   Google Scholar
• WHO. How to investigate drug use in health facilities: selected drug use indicators. 1993. Geneva: WHO/DAP/93.1.
   Google Scholar
• Ng ESW, Carpenter JR, Goldstein H, Rasbash J. Estimation in generalised linear mixed models with binary outcomes by simulated maximum likelihood. Stat Model. 2006; 6: 23–42.
   Web of Science ®Google Scholar
• Rodriguez G, Goldman N. An assessment of estimation procedures for multilevel models with binary responses. J Roy Stat Soc C Appl Stat. 1995; 158: 73–89.
   Web of Science ®Google Scholar
• Dietz E, Clum GA, Chung SE, Leonard L, Murphy DA, Perez LV, etal. Adherence to scheduled appointments among HIV-infected female youth in five U.S. cities. J Adolesc Health. 2010; 46: 278–83. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Farley J, Hines S, Musk A, Ferrus S, Tepper V. Assessment of adherence to antiviral therapy in HIV-infected children using the Medication Event Monitoring System, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping. J Acquir Immune Defic Syndr. 2003; 33: 211–8. [PubMed Abstract].
   Google Scholar
• Wagner GJ, Kanouse DE, Koegel P, Sullivan G. Correlates of HIV antiretroviral adherence in persons with serious mental illness. AIDS Care. 2004; 16: 501–6. [PubMed Abstract].
   Google Scholar
• Gibson TB, Song X, Alemayehu B, Wang SS, Waddell JL, Bouchard JR, etal. Cost sharing, adherence, and health outcomes in patients with diabetes. Am J Manag Care. 2010; 16: 589–600. [PubMed Abstract].
   Google Scholar
• Patel UB, Ni Q, Clayton C, Lam P, Parks J. An attempt to improve antipsychotic medication adherence by feedback of medication possession ratio scores to prescribers. Popul Health Manag. 2010; 13: 269–74. [PubMed Abstract].
   Google Scholar
• Toy EL, Beaulieu NU, McHale JM, Welland TR, Plauschinat CA, Swensen A, etal. Treatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costs. Respir Med. 2011; 105: 435–41. [PubMed Abstract].
   Google Scholar
• Tuppin P, Neumann A, Danchin N, de Peretti C, Weill A, Ricordeau P, etal. Evidence-based pharmacotherapy after myocardial infarction in France: adherence-associated factors and relationship with 30-month mortality and rehospitalization. Arch Cardiovasc Dis. 2010; 103: 363–75. [PubMed Abstract].
   Google Scholar
• Bangsberg DR, Moss AR, Deeks SG. Paradoxes of adherence and drug resistance to HIV antiretroviral therapy. J Antimicrob Chemother. 2004; 53: 696–9. [PubMed Abstract].
   Google Scholar
• Parienti JJ, Das-Douglas M, Massari V, Guzman D, Deeks SG, Verdon R, etal. Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. PLoS One. 2008; 3: e2783. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Bangsberg DR, Kroetz DL, Deeks SG. Adherence–resistance relationships to combination HIV antiretroviral therapy. Curr HIV/AIDS Rep. 2007; 4: 65–72. [PubMed Abstract].
   Google Scholar
• Kasenga F, Byass P, Emmelin M, Hurtig A-K. The implications of policy changes on the uptake of a PMTCT programme in rural Malawi: first three years of experience. Glob Health Action. 2009; 2
   PubMed Web of Science ®Google Scholar
• AVERT. HIV and AIDS in Uganda. Available from: http://www.avert.org/aids-uganda.htm [cited 17 February 2011]..
   Google Scholar
• Mugyenyi P. Flat-line funding for PEPFAR: a recipe for chaos. Lancet. 2009; 374: 292. [PubMed Abstract].
   Google Scholar